A recent study indicates that individuals who discontinue new weight-loss injections like Mounjaro or Wegovy may regain reduced body mass much more quickly than those who stop traditional lifestyle regimens.
Published data in a prominent medical journal demonstrates that while overweight individuals often shed substantial amounts of their body weight while undergoing treatment, the weight returns at an average rate of nearly a kilo each month once they quit.
"People using such treatments need to be informed of the danger of fast rebound weight gain when the therapy ends," stated expert Dr. Susan Jebb.
Such speed of regain suggests a reversion to original weight in about 18 months.
Weighing Treatments
The analysis, which looked at dozens of studies involving thousands of participants, contrasted the outcomes of these new drugs with other pills.
Scientists point out that individuals who shed pounds through dieting usually see a less rapid weight regain—perhaps 0.1 kg a month—after stopping.
Understanding the Rapid Rebound
Doctors suggest the way of the drugs explains the accelerated regain.
These medications imitate a body's own chemical called GLP-1, which helps regulate hunger.
"Artificially providing the hormone concentrations far above than the body's typical production may cause the body to produce less of its own natural GLP-1, and could diminish sensitivity to its effects," said Dr. Adam Collins, a dietetics expert.
"Withdrawal of this GLP-1 'fix' results in hunger is no longer kept in check, making binge eating much more probable."
A Chronic Issue?
Health authorities advise the injections for individuals with obesity-related medical conditions, alongside recommended lifestyle changes.
Many experts contend that, due to the likelihood of weight regain, the therapy might need to be ongoing.
This perspective is reinforced by drug manufacturers, who state that the findings "emphasize the long-term character of obesity," akin to managing diseases like hypertension.
User Experiences
Users who have come off the jabs describe a sudden resurgence of appetite.
"It felt as if a trigger activating and you're instantly ravenous," recalled an individual.
The struggle is worsened if individuals have not adopted sustainable dietary or behavioural changes during treatment.
Significant Adoption
Recent estimates indicate that millions of adults in the UK have tried these injections in the last 12 months, with desire continuing to grow.
- Use is greater among females than men.
- The 40s and 50s demographic shows the highest level of interest.
- Many obtain the drugs through private prescriptions rather than the NHS.
In conclusion, clinicians stress that while the jabs are potent tools for shedding pounds, they are not a standalone solution and long-term success likely depends on combined lifestyle support.
